Log In
Print this Print this

Trilensa (STP503)

  Manage Alerts
Collapse Summary General Information
Company Sirnaomics Inc.
DescriptionShort interfering RNA (SiRNA) therapeutic
Molecular Target
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today